InVitroLogics ApS: Financial statements 2025
CVR: 34044562
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
InVitroLogics ApS (CVR 34044562) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -2,448 and a net result of DKK -2,448 compared with DKK -1,327 the year before. Equity in the 2025 report amounted to DKK -333,763.
- Gross Profit
- DKK -2,448
- Profit/Loss
- DKK -2,448
- Equity
- DKK -333,763
- Total Assets
- DKK 10,234
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -2 t. | -2 t. | -334 t. | - |
| 2024 | - | -1 t. | -1 t. | -331 t. | - |
| 2023 | - | -15 t. | -15 t. | -411 t. | - |
| 2022 | - | -64 t. | -76 t. | -395 t. | 0 |
| 2021 | 48 t. | 48 t. | 37 t. | -319 t. | - |
Official annual report
How creditworthy is InVitroLogics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
InVitroLogics ApS has published its annual report for 2024. Gross profit came to DKK -1,326, and the net result was DKK -1,327.
About InVitroLogics ApS
InVitroLogics ApS is a Danish company of the type Anpartsselskab based in Slagelse, founded in 2011. The company is registered under the industry Detailhandel med andre medicinske og ortopædiske artikler. The management consists of Claus Pedersen Blicher. The company is owned by ADZUKI HOLDING ApS. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,448 and a net result of DKK -2,448 compared with DKK -1,327 the year before. Equity in the 2025 report amounted to DKK -333,763.